Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- N/A
Sacituzumab Govitecan Plus EV in Metastatic UC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
- Status
- COMPLETED
- Phase
- NA
the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of KF-0210 in Advanced Solid Tumors Patients
- Status
- COMPLETED
- Phase
- PHASE1
En Bloc Bladder Tumor Resection: Prospective Randomized Study
- Status
- RECRUITING
- Phase
- NA
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
- Status
- COMPLETED
- Phase
- PHASE3
LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Gender-related Characteristics of Bladder Cancer Treatment
- Status
- UNKNOWN
- Phase
- N/A
Bakircay University Cigli Training and Research Hospital
- Status
- COMPLETED
- Phase
- N/A
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
- Status
- RECRUITING
- Phase
- N/A
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
- Status
- COMPLETED
- Phase
- PHASE1